Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profusa, Inc. - Common Stock (NQ:PFSA)

2.980 -0.180 (-5.70%)
Streaming Delayed Price Updated: 3:21 PM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 329,170
Open 3.210
Bid (Size) 2.950 (100)
Ask (Size) 3.060 (600)
Prev. Close 3.160
Today's Range 2.900 - 3.229
52wk Range 0.0517 - 4.215
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here are the top movers in Thursday's session. ↗
Via Chartmill
Thursday's session: top gainers and losers ↗
Via Chartmill

Performance

YTD
+2880.0%
+2880.0%
1 Month
+3267.2%
+3267.2%
3 Month
+1485.1%
+1485.1%
6 Month
+813.5%
+813.5%
1 Year
+813.5%
+813.5%

More News

Read More
Gapping stocks in Thursday's session ↗
Via Chartmill
Discover the top movers in Thursday's pre-market session. ↗
Via Chartmill
News headline image
Profusa Announces 1-for-75 Reverse Stock Split
From Profusa, Inc.
Via GlobeNewswire
News headline image
$6 Billion Peripheral Artery Disease (PAD) Market: Innovation at a Premium (PFSA, BSX, ABT)
Via AB Newswire
News headline image
Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
From Profusa, Inc.
Via GlobeNewswire
Curious about the most active stocks on Friday? ↗
Via Chartmill
Friday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
From Profusa, Inc.
Via GlobeNewswire
News headline image
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
From Profusa, Inc.
Via GlobeNewswire
Tuesday's after hours session: top gainers and losers ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2025-12-31: top gainers and losers in today's session. ↗
Via Chartmill
The market is filled with gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
Profusa Bolsters European Commercial Network with New French Distributor, MedSell
From Profusa, Inc.
Via GlobeNewswire
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Nika Pharmaceuticals (OTCQB: NIKA) Targets Immune Health Breakthroughs Across HIV, Cancer, and Chronic Diseases
Via AB Newswire
Topics Intellectual Property
Which stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
Most active stocks in Tuesday's session ↗
Via Chartmill
News headline image
Peraso Inc. (NASDAQ: PRSO) Taps $15B U.S. Market as Robotaxi Fleets Hit the Fast Lane
Via AB Newswire
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Top movers in Tuesday's pre-market session ↗
Via Chartmill
News headline image
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35
From Profusa, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Profusa, Inc. - Common Stock publicly traded?
Yes, Profusa, Inc. - Common Stock is publicly traded.
What exchange does Profusa, Inc. - Common Stock trade on?
Profusa, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Profusa, Inc. - Common Stock?
The ticker symbol for Profusa, Inc. - Common Stock is PFSA on the Nasdaq Stock Market
What is the current price of Profusa, Inc. - Common Stock?
The current price of Profusa, Inc. - Common Stock is 2.980
When was Profusa, Inc. - Common Stock last traded?
The last trade of Profusa, Inc. - Common Stock was at 02/10/26 03:21 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.